Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors
Clinical trial NCT07505069 · RECRUITING
Trial details
- NCT number
- NCT07505069
- Sponsor
- Nanolattix Biotechnology Co., Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-29
- Primary completion
- 2026-12-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.